Cojutti, Pier Giorgio; Tedeschi, Sara; Zamparini, Eleonora; Fornaro, Giacomo; Zagarrigo, Manuel; De Paolis, Massimiliano; Viale, Pierluigi; Pea, Federico, Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Staphylococcal osteoarticular Infections?, «ANTIBIOTICS», 2025, 14, Article number: 139, pp. 1 - 14 [articolo]Open Access
Cojutti, Pier Giorgio; Pea, Federico, Is it Time to Move From Intermittent to Continuous Infusion Administration of Vancomycin?, «OPEN FORUM INFECTIOUS DISEASES», 2025, 10.1093/ofid/ofaf203, pp. 1 - 2 [replica/breve intervento]
Cojutti, Pier Giorgio; Gatti, Milo; Tedeschi, Sara; Zamparini, Eleonora; Meschiari, Marianna; Danzi, Maria; Menegotto, Giacomo; Cotrufo, Marco; Soavi, Laura; Chiari, Erika; Ripa, Marco; Mazzitelli, Maria; Crapis, Massimo; Cattelan, Annamaria; Parruti, Giustino; Russo, Alessandro; Zammarchi, Lorenzo; Tascini, Carlo; Viale, Pierluigi; Pea, Federico, Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2025, 69, Article number: e0183024, pp. 1 - 13 [articolo]Open Access
Gatti, Milo; Cojutti, Pier Giorgio; Rinaldi, Matteo; Ambretti, Simone; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Utility of a TDM-Guided Expert Clinical Pharmacological Advice Program for Optimizing the Use of Novel Beta-Lactam/Beta-Lactamase Inhibitor Combinations and Cefiderocol in a Tertiary University Hospital: An Interim Analysis, «THERAPEUTIC DRUG MONITORING», 2025, 10.1097/FTD.0000000000001334, pp. 1 - 12 [articolo]
Conti, Matteo; Giorgi, Beatrice; Barone, Rossella; Gatti, Milo; Cojutti, Pier Giorgio; Pea, Federico, A Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Measuring Fosfomycin Concentrations in Human Prostatic Tissue, «PHARMACEUTICS», 2024, 10.3390/pharmaceutics16050681, Article number: 681, pp. 1 - 12 [articolo]Open Access
Cojutti, Pier Giorgio; Pai, Manjunath P; Gatti, Milo; Rinaldi, Matteo; Ambretti, Simone; Viale, Pierluigi; Pea, Federico, An innovative population pharmacokinetic/pharmacodynamic strategy for attaining aggressive joint PK/PD target of continuous infusion ceftazidime/avibactam against KPC- and OXA-48- producing Enterobacterales and preventing resistance development in critically ill patients, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2024, 10.1093/jac/dkae290, Article number: dkae290, pp. 1 - 12 [articolo]
Cojutti, Pier Giorgio; Pai, Manjunath P.; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing
Enterobacterales, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2024, 68, Article number: e0140423, pp. 1 - 11 [articolo]Open Access
Palombo, Marta; Gatti, Milo; Secci, Benedetta; Cojutti, Pier Giorgio; Pea, Federico; Gibellini, Davide; Gaibani, Paolo, Effect of incremental tazobactam concentrations on the bactericidal activity of piperacillin against ESBL-producing enterobacterales clinical isolates causing bacteraemia, «EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES», 2024, 10.1007/s10096-024-04879-8, pp. 1 - 8 [articolo]
Gatti, Milo; Cojutti, Pier Giorgio; Pea, Federico, Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis, «CRITICAL CARE», 2024, 28(1):123, Article number: 123, pp. 1 - 18 [articolo]Open Access
Troisi, Carla; Cojutti, Pier Giorgio; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; van Hasselt, Coen; Viale, Pierluigi; Pea, Federico, Impact of Continuous Infusion Meropenem PK/PD Target Attainment on C-Reactive Protein Dynamics in Critically Ill Patients With Documented Gram-Negative Hospital-Acquired or Ventilator-Associated Pneumonia, «CLINICAL PHARMACOKINETICS», 2024, 63, pp. 1573 - 1583 [articolo]Open Access
Gatti, Milo; Cojutti, Pier Giorgio; Pea, Federico, Piperacillin-tazobactam vs. carbapenems for treating hospitalized patients with ESBL-producing Enterobacterales bloodstream infections: a systematic review and meta-analysis, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2024, 39, pp. 27 - 36 [articolo]Open Access
Cojutti, Pier Giorgio; Tedeschi, Sara; Zamparini, Eleonora; Viale, Pierluigi; Pea, Federico, Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections, «CLINICAL PHARMACOKINETICS», 2024, 63, pp. 1271 - 1282 [articolo]Open Access
Cojutti, Pier Giorgio; Pea, Federico, Azacitidine for Acute Myeloid Leukemia: Why One Dose Does Not Fit All, «CLINICAL PHARMACOLOGY & THERAPEUTICS», 2023, 10.1002/cpt.3154, pp. 1 - 1 [replica/breve intervento]
Cojutti, Pier Giorgio; Giuliano, Simone; Pascale, Renato; Angelini, Jacopo; Tascini, Carlo; Viale, Pierluigi; Pea, Federico, Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal Infections, «MICROORGANISMS», 2023, 10.3390/microorganisms11122964, pp. 1 - 13 [articolo]Open Access
Gatti M.; Virgili G.; Cojutti P.G.; Gaibani P.; Conti M.; Sturiale C.; Pea F.; Viale P., Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases, «MICROORGANISMS», 2022, 10, Article number: 154, pp. 1 - 8 [articolo]Open Access
